Variant report
Variant | esv3385404 |
---|---|
Chromosome Location | chr8:107880111-107882240 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:107881925..107884632-chr8:107886674..107888381,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184818258 | chr8:107880161-107880162 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs371637425 | chr8:107880183-107880184 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187845090 | chr8:107880185-107880186 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533132964 | chr8:107880214-107880215 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551518139 | chr8:107880226-107880227 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569727178 | chr8:107880299-107880300 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192758069 | chr8:107880306-107880307 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183488087 | chr8:107880347-107880348 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548743042 | chr8:107880351-107880352 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148655788 | chr8:107880395-107880396 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189484053 | chr8:107880442-107880443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142172551 | chr8:107880448-107880449 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115256355 | chr8:107880502-107880503 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181868061 | chr8:107880535-107880536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375829406 | chr8:107880540-107880541 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557830942 | chr8:107880557-107880558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs60948209 | chr8:107880580-107880581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs370262401 | chr8:107880593-107880594 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576174276 | chr8:107880630-107880631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs77236239 | chr8:107880642-107880643 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561865123 | chr8:107880652-107880653 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561976981 | chr8:107880659-107880660 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs184439121 | chr8:107880698-107880699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs190187614 | chr8:107880737-107880738 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs578028041 | chr8:107880766-107880767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs151157752 | chr8:107880783-107880784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533173166 | chr8:107880807-107880808 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs16875208 | chr8:107880864-107880865 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs181527561 | chr8:107880884-107880885 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186660149 | chr8:107880890-107880891 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561145276 | chr8:107880894-107880895 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549040867 | chr8:107880916-107880917 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189375580 | chr8:107880937-107880938 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs139093167 | chr8:107880964-107880965 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs73702460 | chr8:107880997-107880998 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs73702461 | chr8:107881005-107881006 | Weak transcription Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs560352009 | chr8:107881031-107881032 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565983448 | chr8:107881052-107881053 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539738570 | chr8:107881127-107881128 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs79247504 | chr8:107881161-107881162 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113385111 | chr8:107881279-107881280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs77658145 | chr8:107881294-107881295 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555804567 | chr8:107881313-107881314 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144065558 | chr8:107881332-107881333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541376461 | chr8:107881336-107881337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553307967 | chr8:107881343-107881344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs578033070 | chr8:107881360-107881361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs545308259 | chr8:107881397-107881398 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs16875210 | chr8:107881453-107881454 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs56852936 | chr8:107881477-107881478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastric cancer | 22539939 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:107876800-107886400 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
2 | chr8:107879200-107881800 | Weak transcription | A549 | lung |
3 | chr8:107879800-107880400 | Active TSS | Aorta | Aorta |
4 | chr8:107880400-107880800 | Enhancers | Aorta | Aorta |
5 | chr8:107880800-107881200 | Active TSS | Aorta | Aorta |
6 | chr8:107881000-107881200 | Enhancers | HSMMtube | muscle |
7 | chr8:107881200-107881400 | Enhancers | Aorta | Aorta |
8 | chr8:107881200-107886000 | Weak transcription | HSMMtube | muscle |
9 | chr8:107881400-107883000 | Weak transcription | Aorta | Aorta |
10 | chr8:107881800-107882600 | Enhancers | A549 | lung |
11 | chr8:107882200-107882800 | Enhancers | HSMM | muscle |
12 | chr8:107882200-107883200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr8:107882200-107883200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr8:107882200-107883400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |